36
Participants
Start Date
February 29, 2008
Primary Completion Date
February 28, 2010
Study Completion Date
February 28, 2010
TM-601
TM-601, administered intravenously (IV), once/week for 3 weeks
Columbia University, New York
Northwestern University, Chicago
Washington University, St Louis
Cedars-Sinai Medical Center, Los Angeles
University of Alabama, Birmingham
Wake Forest University, Winston-Salem
University of Washington, Seattle
Lead Sponsor
TransMolecular
INDUSTRY